- Telehealth Visits
- Insurance plan information
Alain P. Algazi, MD
Head and Neck Medical Oncology- Telehealth Visits
- Insurance plan information
Alain P. Algazi, MD
Head and Neck Medical Oncology- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Alain Algazi is a specialist in medical treatment – such as chemotherapy and immunotherapy – for patients with head and neck cancers, including head and neck squamous cell carcinoma, thyroid cancers and salivary gland cancers. He leads UCSF's program in medical therapy for head and neck cancers, and chairs the head and neck cancer research committee.
In research, Algazi conducts clinical trials – studies that evaluate new therapies for head and neck cancers with an emphasis on approaches to improving the chances of long term remission in patients with incurable cancer using immunotherapy. He has also served the national study chair for clinical trials that give patients access to new medications and that provide new approaches of administering existing medications to improve their efficacy.
Algazi earned his medical degree from the David Geffen School of Medicine at UCLA and completed a residency in internal medicine at Ronald Reagan UCLA Medical Center. He completed a fellowship in hematology-oncology at UCSF.
Algazi is a member of the American Society of Clinical Oncology, Society for Immunotherapy for Cancer and American Association for Cancer Research.
To reach Dr. Alain Algazi, please contact the head and neck medical oncology practice at (415) 353-9900.
Education & training
Board certification
- Medical Oncology, American Board of Internal Medicine
Fellowship
- Medical Oncology & Hematology, UCSF Graduate Medical Education
Residency
- Internal Medicine, University of California Los Angeles
Internship
- Internal Medicine, University of California Los Angeles
Degree
- MD, University of California Los Angeles
My expertise
Specialties
Conditions
- Thyroid Cancer
- Melanoma
- Neoplasm of Salivary Gland
- Head and Neck Cancer
Locations
My research
Clinical trials
Preoperative Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and NeckOpens in a new window
Recruiting
Intratumoral CD3+ T-cells will be identified by immunohistochemistry in pre- and post-treatment tumor specimens. The analysis population for the primary…
Publications
Showing 1-6 of 55 reviews
- November 24, 20255 out of 5 Stars
I am a long time patient and have been treated very well
- November 5, 20255 out of 5 Stars
Very good
- October 17, 20255 out of 5 Stars
The physician listened and answered all our questions about existing conditions and future treatments.
- October 9, 20255 out of 5 Stars
Very knowledgeable and very supportive
- October 8, 20255 out of 5 Stars
He listened and worked out a plan that worked for both of us
- August 29, 20254.9 out of 5 Stars
Felt very well informed after the call.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.